Catalyst Biosciences (NASDAQ:CBIO) reported quarterly earnings of $1.64 per share. This is a 356.25 percent increase over losses of $(0.64) per share from the same period last year.
READ: Full Study Titled ‘Antibody responses to Omicron BA.4/BA.5 bivalent mRNA vaccine booster shot’
https://www.biorxiv.org/content/10.1101/2022.10.22.513349v1.full.pdf
https://www.biorxiv.org/content/10.1101/2022.10.22.513349v1